4.6 Article

Contribution of astrocytes to familial risk and clinical manifestation of schizophrenia

Journal

GLIA
Volume 70, Issue 4, Pages 650-660

Publisher

WILEY
DOI: 10.1002/glia.24131

Keywords

calcium imaging; cell transplantation; extracellular matrix; induced pluripotent stem cells; monozygotic twins; RNA sequencing

Categories

Funding

  1. Academy of Finland [AK 266820, A334525, AK 332354, 312073]
  2. French National Agency for Research, ANR, Eranet Neuron III program (Acrobat)
  3. Sigrid Juselius Foundation
  4. Business Finland
  5. Paijat-Hame Regional Fund
  6. Instrumentarium Science Foundation
  7. Orion Research Foundation

Ask authors/readers for more resources

Previous studies have shown that genetic impact of astrocytes in schizophrenia (SCZ) is unknown. Human induced pluripotent stem cell (hiPSC)-derived astrocytes from SCZ twins exhibit gene expression alterations related to synaptic dysfunction, inflammation, and extracellular matrix components. The transplantation of SCZ astrocytes into the mouse forebrain resulted in gene expression changes in brain cells and behavioral changes in cognitive and olfactory functions. Abnormal extracellular matrix composition in the brain is one of the key characteristics in the etiology of SCZ.
Previous studies have implicated several brain cell types in schizophrenia (SCZ), but the genetic impact of astrocytes is unknown. Considering their high complexity in humans, astrocytes are likely key determinants of neurodevelopmental diseases, such as SCZ. Human induced pluripotent stem cell (hiPSC)-derived astrocytes differentiated from five monozygotic twin pairs discordant for SCZ and five healthy subjects were studied for alterations related to high genetic risk and clinical manifestation of SCZ in astrocyte transcriptomics, neuron-astrocyte co-cultures, and in humanized mice. We found gene expression and signaling pathway alterations related to synaptic dysfunction, inflammation, and extracellular matrix components in SCZ astrocytes, and demyelination in SCZ astrocyte transplanted mice. While Ingenuity Pathway Analysis identified SCZ disease and synaptic transmission pathway changes in SCZ astrocytes, the most consistent findings were related to collagen and cell adhesion associated pathways. Neuronal responses to glutamate and GABA differed between astrocytes from control persons, affected twins, and their unaffected co-twins and were normalized by clozapine treatment. SCZ astrocyte cell transplantation to the mouse forebrain caused gene expression changes in synaptic dysfunction and inflammation pathways of mouse brain cells and resulted in behavioral changes in cognitive and olfactory functions. Differentially expressed transcriptomes and signaling pathways related to synaptic functions, inflammation, and especially collagen and glycoprotein 6 pathways indicate abnormal extracellular matrix composition in the brain as one of the key characteristics in the etiology of SCZ.

Authors

I am an author on this paper
Click your name to claim this paper and add it to your profile.

Reviews

Primary Rating

4.6
Not enough ratings

Secondary Ratings

Novelty
-
Significance
-
Scientific rigor
-
Rate this paper

Recommended

No Data Available
No Data Available